• 25 Hits
  • Search Condition : Filter (MeSH = Endometrial Neoplasms / genetics)
Species Resource Title
Human and Animal Cells QG-U(RCB0688) Selective expression of HERG and Kv2 channels influences proliferation of uterine cancer cells.
Human and Animal Cells HOUA-I(RCB0659) MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.
Human and Animal Cells Sawano(RCB1152) MicroRNA-152 Regulates Endometrial Serous Carcinoma Cell Motility by Suppressing Matrix Metalloproteinase 10 Expression.
Human and Animal Cells HHUA(RCB0658) Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway.
Human and Animal Cells Sawano(RCB1152) Retinoic Acid Receptor β: A Potential Therapeutic Target in Retinoic Acid Treatment of Endometrial Cancer.
Human and Animal Cells HOUA-I(RCB0659) EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis.
Human and Animal Cells JHUEM-1(RCB1548) Nanopore sequencing reveals TACC2 locus complexity and diversity of isoforms transcribed from an intronic promoter.
Human and Animal Cells HHUA(RCB0658) Telmisartan induces growth inhibition, DNA double-strand breaks and apoptosis in human endometrial cancer cells.
Human and Animal Cells HHUA(RCB0658) Suppressed protein expression of the death-associated protein kinase enhances 5-fluorouracil-sensitivity but not etoposide-sensitivity in human endometrial adenocarcinoma cells.
Human and Animal Cells HHUA(RCB0658) Targeted knockdown of death-associated protein kinase expression induces TRAIL-mediated apoptosis in human endometrial adenocarcinoma cells.
Human and Animal Cells HHUA(RCB0658) An upstream estrogen response element linked to exogenous p53 tumor suppressor gene expression differentiates effects of the codon 72 polymorphism.
Human and Animal Cells HHUA(RCB0658) Dual-specificity phosphatase 6 plays a critical role in the maintenance of a cancer stem-like cell phenotype in human endometrial cancer.
Human and Animal Cells HHUA(RCB0658) Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-FOXO1 signal pathway.
Human and Animal Cells JHUEM-1(RCB1548) Proteomic profiling of FBXW7-mutant serous endometrial cancer cells reveals upregulation of PADI2, a potential therapeutic target.
Human and Animal Cells JHUEM-2(RCB1551) PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2mutant Endometrial Cancers.
Human and Animal Cells Sawano(RCB1152) Loss of tricellular tight junction protein LSR promotes cell invasion and migration via upregulation of TEAD1/AREG in human endometrial cancer.
Human and Animal Cells HHUA(RCB0658) Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer.
Human and Animal Cells HHUA(RCB0658) Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells.
Human and Animal Cells JHUEM-2(RCB1551) The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors.
Human and Animal Cells JHUEM-3(RCB1552) PI3K pathway dependencies in endometrioid endometrial cancer cell lines.